Stock ScreenerStock IdeasStrong Buys According to Wall StreetStrong Buys According to Wall StreetCompanies with high upside and a consensus strong buy recommendation from Wall Street analysts
Stock ScreenerStock IdeasStrong Buys According to Wall Street
Consensus: Strong Buy
Analysts: >= 3
Upside/Downside: Large Upside
| Ticker | Company | Market Cap | Price | Price Target | Upside/Downside | Top Analysts Upside/Downside | Consensus | Top Analysts Consensus | Analysts | Top Analysts | Fore. Revenue Growth | Fore. Earnings Growth | Forecast ROE | Forecast ROA |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| XOMA | XOMA ROYALTY CORP | $312.30M | $25.22 | $72.67 | 188.13% | Strong Buy | 3 | 13.23% | -0.86% | 17.10% | 5.71% | |||
| AKA | AKA BRANDS HOLDING CORP | $126.08M | $11.74 | $24.33 | 107.27% | Strong Buy | 3 | 1.91% | N/A | -13.20% | -3.53% | |||
| DMAC | DIAMEDICA THERAPEUTICS INC | $489.01M | $9.39 | $15.50 | 65.07% | Strong Buy | 4 | N/A | N/A | -91.58% | -82.87% | |||
| NTGR | NETGEAR INC | $697.86M | $24.57 | $39.00 | 58.73% | Strong Buy | 3 | 3.96% | N/A | 6.23% | 3.89% | |||
| CHYM | CHIME FINANCIAL INC | $9.81B | $26.19 | $33.14 | 26.55% | Strong Buy | 14 | N/A | N/A | N/A | N/A | |||
| ENTA | ENANTA PHARMACEUTICALS INC | $425.15M | $14.73 | $20.40 | 38.49% | Strong Buy | 5 | 1.85% | N/A | -103.15% | -23.78% | |||
| CGTX | COGNITION THERAPEUTICS INC | $149.18M | $1.69 | $3.33 | 97.22% | Strong Buy | 3 | N/A | N/A | -157.75% | -132.79% | |||
| OTLY | OATLY GROUP AB | $351.07M | $11.58 | $16.67 | 43.93% | Strong Buy | 3 | 4.09% | N/A | -1,125.13% | -26.97% | |||
| CRVO | CERVOMED INC | $78.19M | $8.45 | $22.80 | 169.82% | Strong Buy | 5 | N/A | N/A | -44.99% | -38.23% | |||
| RZLT | REZOLUTE INC | $166.91M | $1.80 | $13.00 | 622.22% | Strong Buy | 5 | N/A | N/A | -8.03% | -7.45% | |||
| BSVN | BANK7 CORP | $416.80M | $44.09 | $53.33 | 20.96% | Strong Buy | 3 | 2.36% | -1.94% | 17.74% | 2.27% | |||
| KYMR | KYMERA THERAPEUTICS INC | $6.45B | $89.68 | $112.89 | 25.88% | Strong Buy | 18 | 5.90% | N/A | -34.08% | -29.26% | |||
| PHR | PHREESIA INC | $979.66M | $16.25 | $31.75 | 95.38% | Strong Buy | 16 | 9.57% | N/A | 12.74% | 9.64% | |||
| SMWB | SIMILARWEB LTD | $645.40M | $7.48 | $13.00 | 73.80% | Strong Buy | 3 | 11.64% | N/A | N/A | N/A | |||
| CYBN | CYBIN INC | $153.86M | $6.68 | $49.33 | 638.52% | Strong Buy | 3 | N/A | N/A | -78.27% | -60.02% | |||
| ICHR | ICHOR HOLDINGS LTD | $612.73M | $17.82 | $26.50 | 48.71% | Strong Buy | 4 | 4.88% | N/A | 9.49% | 6.64% | |||
| PRQR | PROQR THERAPEUTICS NV | $250.97M | $2.33 | $6.67 | 186.14% | Strong Buy | 3 | -17.95% | N/A | N/A | N/A | |||
| TBPH | THERAVANCE BIOPHARMA INC | $920.72M | $18.17 | $27.80 | 53.00% | Strong Buy | 5 | 15.59% | -48.81% | 17.92% | 10.04% | |||
| SGMT | SAGIMET BIOSCIENCES INC | $202.61M | $6.23 | $29.80 | 378.33% | Strong Buy | 5 | N/A | N/A | -62.31% | -57.87% | |||
| ELVN | ENLIVEN THERAPEUTICS INC | $1.00B | $16.86 | $45.67 | 170.86% | Strong Buy | 3 | N/A | N/A | -28.48% | -27.62% | |||
| CTNM | CONTINEUM THERAPEUTICS INC | $339.39M | $11.63 | $19.25 | 65.52% | Strong Buy | 4 | N/A | N/A | -41.81% | -39.54% | |||
| XNCR | XENCOR INC | $1.18B | $16.52 | $24.50 | 48.31% | Strong Buy | 8 | -3.95% | N/A | -25.33% | -18.23% | |||
| PSN | PARSONS CORP | $6.74B | $63.33 | $84.55 | 33.50% | Strong Buy | 11 | 3.64% | 0.12% | 17.20% | 7.67% | |||
| ATR | APTARGROUP INC | $7.97B | $121.47 | $167.50 | 37.89% | Strong Buy | 4 | 3.46% | -0.75% | 16.30% | 8.85% | |||
| SYRE | SPYRE THERAPEUTICS INC | $2.61B | $33.62 | $59.00 | 75.49% | Strong Buy | 3 | N/A | N/A | -52.71% | -47.54% | |||
| ORIC | ORIC PHARMACEUTICALS INC | $913.51M | $9.38 | $19.50 | 107.89% | Strong Buy | 10 | N/A | N/A | -41.74% | -39.39% | |||
| FBRX | FORTE BIOSCIENCES INC | $267.70M | $21.37 | $67.00 | 213.52% | Strong Buy | 3 | N/A | N/A | -54.70% | -47.38% | |||
| PVLA | PALVELLA THERAPEUTICS INC | $1.17B | $98.58 | $142.69 | 44.75% | Strong Buy | 13 | N/A | N/A | -96.72% | -55.89% | |||
| RIOT | RIOT PLATFORMS INC | $5.69B | $15.30 | $27.05 | 76.76% | Strong Buy | 11 | 9.98% | N/A | N/A | N/A | |||
| IBIO | IBIO INC | $43.63M | $1.94 | $4.00 | 106.19% | Strong Buy | 3 | -21.59% | N/A | -14.12% | -12.33% | |||
| TNGX | TANGO THERAPEUTICS INC | $1.26B | $9.35 | $12.40 | 32.62% | Strong Buy | 5 | -47.67% | N/A | -100.37% | -76.44% | |||
| TVRD | TVARDI THERAPEUTICS INC | $41.37M | $4.41 | $47.50 | 977.10% | Strong Buy | 4 | N/A | N/A | -102.26% | -73.03% | |||
| IDYA | IDEAYA BIOSCIENCES INC | $2.98B | $34.02 | $49.18 | 44.57% | Strong Buy | 11 | -28.36% | N/A | -22.71% | -20.92% | |||
| BITF | BITFARMS LTD | $1.54B | $2.74 | $3.67 | 33.83% | Strong Buy | 3 | 5.47% | N/A | -14.09% | -10.75% | |||
| NAVN | NAVAN INC | N/A | $14.55 | $25.50 | 75.26% | Strong Buy | 10 | N/A | N/A | N/A | -0.36% | |||
| CCCC | C4 THERAPEUTICS INC | $239.38M | $2.47 | $8.50 | 244.13% | Strong Buy | 4 | -12.41% | N/A | 5.44% | 3.16% | |||
| TYRA | TYRA BIOSCIENCES INC | $1.21B | $22.63 | $31.67 | 39.93% | Strong Buy | 3 | N/A | N/A | -21.35% | -19.84% | |||
| BLLN | BILLIONTOONE INC | $4.67B | $101.99 | $137.83 | 35.14% | Strong Buy | 6 | N/A | N/A | N/A | N/A | |||
| OCUL | OCULAR THERAPEUTIX INC | $3.10B | $14.56 | $23.25 | 59.68% | Strong Buy | 8 | 15.90% | N/A | -52.18% | -32.79% | |||
| CLFD | CLEARFIELD INC | $410.19M | $29.64 | $43.50 | 46.76% | Strong Buy | 4 | 17.34% | N/A | 7.03% | 5.88% | |||
| TRVI | TREVI THERAPEUTICS INC | $1.64B | $12.77 | $21.63 | 69.34% | Strong Buy | 8 | N/A | N/A | -35.23% | -33.54% | |||
| NEXN | NEXXEN INTERNATIONAL LTD | $198.73M | $6.68 | $11.83 | 77.14% | Strong Buy | 6 | N/A | N/A | 5.81% | 3.66% | |||
| IMTX | IMMATICS NV | $1.22B | $10.04 | $22.33 | 122.44% | Strong Buy | 3 | -15.95% | N/A | -36.76% | -29.54% | |||
| CARL | CARLSMED INC | $344.38M | $12.95 | $20.25 | 56.37% | Strong Buy | 4 | N/A | N/A | -27.21% | -21.52% | |||
| TIGR | UP FINTECH HOLDING LTD | $1.64B | $9.24 | $14.20 | 53.68% | Strong Buy | 3 | 9.98% | 3.43% | N/A | N/A | |||
| SLDB | SOLID BIOSCIENCES INC | $457.33M | $5.87 | $14.14 | 140.94% | Strong Buy | 7 | N/A | N/A | -42.51% | -33.83% | |||
| OMDA | OMADA HEALTH INC | $874.41M | $15.10 | $26.44 | 75.13% | Strong Buy | 9 | N/A | N/A | 7.03% | 5.31% | |||
| CGEM | CULLINAN THERAPEUTICS INC | $704.19M | $11.92 | $31.50 | 164.26% | Strong Buy | 4 | N/A | N/A | -44.86% | -41.82% | |||
| ALEC | ALECTOR INC | $162.64M | $1.49 | $4.50 | 202.01% | Strong Buy | 3 | -18.74% | N/A | -238.57% | -41.06% | |||
| CMPX | COMPASS THERAPEUTICS INC | $917.77M | $5.16 | $14.20 | 175.19% | Strong Buy | 5 | N/A | N/A | 6.49% | 5.88% | |||
| CATX | PERSPECTIVE THERAPEUTICS INC | $198.48M | $2.67 | $10.83 | 305.73% | Strong Buy | 6 | -16.17% | N/A | -35.45% | -29.13% | |||
| VTYX | VENTYX BIOSCIENCES INC | $584.43M | $8.19 | $14.60 | 78.27% | Strong Buy | 5 | N/A | N/A | -38.16% | -34.53% | |||
| AIRG | AIRGAIN INC | $48.43M | $4.05 | $6.33 | 56.37% | Strong Buy | 3 | -1.84% | N/A | 3.90% | 2.54% | |||
| EYPT | EYEPOINT PHARMACEUTICALS INC | $1.32B | $15.99 | $29.67 | 85.53% | Strong Buy | 3 | 11.99% | N/A | -24.89% | -19.79% | |||
| OLMA | OLEMA PHARMACEUTICALS INC | $2.27B | $33.05 | $40.50 | 22.54% | Strong Buy | 6 | N/A | N/A | -54.66% | -47.69% | |||
| LXEO | LEXEO THERAPEUTICS INC | $713.09M | $9.77 | $19.83 | 103.00% | Strong Buy | 6 | N/A | N/A | -74.24% | -62.37% | |||
| T | AT&T INC | $174.26B | $24.58 | $31.00 | 26.12% | Strong Buy | 13 | 1.92% | -6.39% | 17.41% | 4.55% | |||
| NRIX | NURIX THERAPEUTICS INC | $1.47B | $19.07 | $26.70 | 40.01% | Strong Buy | 10 | -11.52% | N/A | -64.73% | -46.12% | |||
| NTSK | NETSKOPE INC | $8.15B | $20.72 | $27.08 | 30.68% | Strong Buy | 13 | N/A | N/A | -83.14% | -7.32% |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.